Ranbaxy Laboratories’ JV inks 'letter of offer' agreement with KHTP

08 Aug 2013 Evaluate

Ranbaxy Malaysia Sdn Bhd (RMSB) is a joint venture company of Ranbaxy Laboratories and has been allocated the site for setting up its Greenfield manufacturing facility in Malaysia. The company signed a 'letter of offer' agreement with Kulim Hi Tech Park (KHTP), a wholly owned state agency and industrial park that houses various other leading industries. KHTP is located at Kulim in the state of Kedah, Malaysia.

The Ranbaxy Greenfield facility will be built on an area of around 15 acres with an investment of around US$ 35 million providing employment to over 200 people. This will be Ranbaxy's second manufacturing plant in Malaysia. Last year in September, the Government of Malaysia gave an approval to RMSB for setting up a Greenfield manufacturing facility in Malaysia as an Entry Point Project (EPP).

The RMSB new facility would manufacture dosage forms including tablets and capsules primarily in the Cardiovascular, Anti Diabetic, Anti-infective and Gastrointestinal segments. Ranbaxy's total output in Malaysia will be increased from 1 Billion doses /annum to 3 Billion doses /annum when the new facility is fully operational. In the 2012 Malaysian budget, the Government of Malaysia liberalized investments into the healthcare sector and encouraged foreign companies.

Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×